20 research outputs found

    Cumulative asbestos exposure and mortality from asbestos related diseases in a pooled analysis of 21 asbestos cement cohorts in Italy

    Get PDF
    Background: Despite the available information on cancer risk, asbestos is used in large areas in the world, mostly in the production of asbestos cement. Moreover, questions are raised regarding the shape of the dose response relation, the relation with time since exposure and the association with neoplasms in various organs. We conducted a study on the relationship between cumulative asbestos exposure and mortality from asbestos related diseases in a large Italian pool of 21 cohorts of asbestos-cement workers with protracted exposure to both chrysotile and amphibole asbestos. Methods: The cohort included 13,076 workers, 81.9% men and 18.1% women, working in 21 Italian asbestos-cement factories, with over 40 years of observation. Exposure was estimated by plant and period, and weighted for the type of asbestos used. Data were analysed with consideration of cause of death, cumulative exposure and time since first exposure (TSFE), and by gender. SMRs were computed using reference rates by region, gender and calendar time. Poisson regression models including cubic splines were used to analyse the effect of cumulative exposure to asbestos and TSFE on mortality for asbestos-related diseases. 95% Confidence Intervals (CI) were computed according to the Poisson distribution. Results: Mortality was significantly increased for ‘All Causes’ and ‘All Malignant Neoplasm (MN)’, in both genders. Considering asbestos related diseases (ARDs), statistically significant excesses were observed for MN of peritoneum (SMR: men 14.19; women 15.14), pleura (SMR: 22.35 and 48.10), lung (SMR: 1.67 and 1.67), ovary (in the highest exposure class SMR 2.45), and asbestosis (SMR: 507 and 1023). Mortality for ARDs, in particular pleural and peritoneal malignancies, lung cancer, ovarian cancer and asbestosis increased monotonically with cumulative exposure. Pleural MN mortality increased progressively in the first 40 years of TSFE, then reached a plateau, while peritoneal MN showed a continuous increase. The trend of lung cancer SMRs also showed a flattening after 40 years of TSFE. Attributable proportions for pleural, peritoneal, and lung MN were respectively 96, 93 and 40%. Conclusions: Mortality for ARDs was associated with cumulative exposure to asbestos. Risk of death from pleural MN did not increase indefinitely with TSFE but eventually reached a plateau, consistently with reports from other recent studie

    Italian pool of asbestos workers cohorts: asbestos related mortality by industrial sector and cumulative exposure

    Get PDF
    Objective. Italy has been a large user of asbestos and asbestos containing materials until the 1992 ban. We present a pooled cohort study on long-term mortality in exposed workers. Methods. Pool of 43 Italian asbestos cohorts (asbestos cement, rolling stock, shipbuilding, glasswork, harbors, insulation and other industries). SMRs were computed by industrial sector for the 1970-2010 period, for the major causes, using reference rates by age, sex, region and calendar period. Results. The study included 51 801 subjects (5741 women): 55.9% alive, 42.6% died (cause known for 95%) and 1.5% lost to follow-up. Asbestos exposure was estimated at the plant and period levels. Asbestos related mortality was significantly increased. All industrial sectors showed increased mortality from pleural malignancies, and most als

    Efficacia degli antibotritici: effetti della distribuzione su vite

    No full text
    La modalità con cui la miscela viene distribuita sul bersaglio influisce sul deposito sulla vegetazione, ma soprattutto sulla sua efficacia. Le prove svolte con ugelli diversi per trattamenti antibotritici su pergola trentina doppia non hanno evidenziato differenze sul grado di copertura del grappolo tra ugelli a cono vuoto e antideriva a iniezione d’aria. Inoltre dalle prove è emerso che l’impiego dei 500 L/ha del prodotto testato, in 2 passaggi opposti l’un l’altro sotto l’ala, ha favorito l’incremento dei depositi medi sia sulla vegetazione sia sui grappol

    Knowledge, Attitudes and Practices of Agricultural Workers towards Tetanus Vaccine: a Field Report

    No full text
    Background. Agricultural Workers are both more exposed to tetanus and at higher risk to be inadequately immunized than other usual recipients of the same vaccine Study design. Our cross-sectional questionnaire-based study aimed to evaluate tetanus vaccination status, knowledge, attitudes and practices in Agricultural Workers in North-Eastern Italy. Methods. Bivariate and multivariate logistic regression analyses were used to identify, from individual and work-related characteristics, factors significantly associated with appropriate vaccination status. Results. Among 707 participants, 58.4% had an up-to-date immunization status. In 33.1%, last booster was performed by an Emergency Department. The main reason for inadequate immunization was having forgotten the recommended periodic booster (146/707; 20.7%). Attitude towards tetanus vaccination was somehow favourable in 79.5% of participants, and 72.7% correctly identified tetanus vaccination as mandatory for Agricultural Workers. A lower degree of false beliefs and better knowledge of official recommendations were significant predictors of vaccine propensity. The main predictor for an appropriate vaccination status was interaction with a healthcare provider, in general (adjusted Odds Ratio, adjOR 2.516 95%CI 1.707-3.710), and specifically regarding vaccine counseling, (adjOR 6.275 3.184-12.367 and adjOR 9.739 95%CI 3.933-24.111 for general practitioners and occupational physicians, respectively). Conclusions. Our study enlightens the key role of healthcare providers in recalling and promoting vaccination policies, as well in increasing the general awareness of Agricultural Workers regarding vaccines and official recommendations

    Prove di contenimento delle popolazioni di Cacopsylla pruni vettore del giallume europeo delle drupacee

    No full text
    Vengono presentati i risultati di alcune sperimentazioni effettuate per valutare l'influenza su Cacopsylla pruni e sulla diffusione del fitoplasma agente del giallume europeo delle drupacee (ESFY) di alcune strategie di difesa adottate nei pescheti contro gli afidi e i tripidi. Dai dati raccolti emerge che per contenere la diffusione della malattia non \ue8 sufficiente un solo trattamento aficida effettuato in pre fioritura; mentre due (pre e post fioritura) o tre (pre, post fioritura e scamiciatura) intreventi insetticidi sortiscono uguali risultati sia sul vettore sia sulla riduzione della percentuale di nuove piante ammalate. Con prove di semicampo \ue8 stata inoltre valutata l'efficacia nei confronti delle forme mobili di C. pruni degli insetticidi normalmente impiegati in peschicoltura in primavera

    Studi epidemiologici sul giallume europeo delle drupacee (ESFY) in impianti peschicoli del veronese

    No full text
    Vengono riportati i risultati di indagini effettuati nel decennio 1995-2004 per il monitoraggio di ESFY in numerosi pescheti della provincia di Verona, nonch\ue8 sulla presenza di psillidi infetti dal patogeno e sulla presenza di piante spontanee, possibili serbatoio d'inoculo per ESFYP nelle stesse aree. E' stato verificato un progressivo incremento della malattia (2% medio di nuove infezioni ogni anno), la presenza di piante spontanee di prugnolo e mirabolano infette e di numerosi individui di Cacopsylla pruni infetti da ESFYP

    Changes in life expectancy for cancer patients over time since diagnosis

    Get PDF
    The aims of this study were to provide life expectancy (LE) estimates of cancer patients at diagnosis and LE changes over time since diagnosis to describe the impact of cancer during patients' entire lives. Cancer patients' LE was calculated by standard period life table methodology using the relative survival of Italian patients diagnosed in population-based cancer registries in 1985-2011 with follow-up to 2013. Data were smoothed using a polynomial model and years of life lost (YLL) were calculated as the difference between patients' LE and that of the age- and sex-matched general population. The YLL at diagnosis was highest at the youngest age at diagnosis, steadily decreasing thereafter. For patients diagnosed at age 45 years, the YLL was above 20 for lung and ovarian cancers and below 6 for thyroid cancer in women and melanoma in men. LE progressively increased in patients surviving the first years, decreasing thereafter, to approach that of the general population. YLL in the long run mainly depends on attained age. Providing quantitative data is essential to better define clinical follow-up and plan health care resource allocation. These results help assess when the excess risk of death from tumour becomes negligible in cancer survivors

    Prognosis and cure of long-term cancer survivors: A population-based estimation

    Get PDF
    Background Increasing evidence of cure for some neoplasms has emerged in recent years. The study aimed to estimate population-based indicators of cancer cure. Methods Information on more than half a million cancer patients aged 15-74 years collected by population-based Italian cancer registries and mixture cure models were used to estimate the life expectancy of fatal tumors (LEFT), proportions of patients with similar death rates of the general population (cure fraction), and time to reach 5-year conditional relative survival (CRS) >90% or 95% (time to cure). Results Between 1990 and 2000, the median LEFT increased >1 year for breast (from 8.1 to 9.4 years) and prostate cancers (from 5.2 to 7.4 years). Median LEFT in 1990 was >5 years for testicular cancers (5.8) and Hodgkin lymphoma (6.3) below 45 years of age. In both sexes, it was <= 0.5 years for pancreatic cancers and NHL in 1990 and in 2000. The cure fraction showed a 10% increase between 1990 and 2000. It was 95% for thyroid cancer in women, 94% for testis, 75% for prostate, 67% for breast cancers, and <20% for liver, lung, and pancreatic cancers. Time to 5-year CRS >95% was <10 years for testis, thyroid, colon cancers, and melanoma. For breast and prostate cancers, the 5-year CRS >90% was reached in 15 years. Conclusions The study findings confirmed that several cancer types are curable. Became aware of the possibility of cancer cure has relevant clinical and social impacts
    corecore